Buchang Pharmaceuticals

Buchang Pharmaceuticals is one of the...

• CSI 500.

Buchang Pharmaceuticals is a company listed under the stock ticker 603858 (CN).

View the org chart displaying its 16 main executives

Most searched biographies at Buchang Pharmaceuticals

• Chao Zhao, President and Director
• Jing Zhao, Vice Chairman of the Board
• Zhao Tao, Chairman of the Board

Create your alert
to follow the executive moves at Buchang Pharmaceuticals.

Buchang Pharmaceuticals has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Buchang Pharmaceuticals

Social media about Buchang Pharmaceuticals

• Buchang Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Buchang Pharmaceuticals on LinkedIn, Twitter & YouTube

Call Buchang Pharmaceuticals at +86 6-...

View the org chart

Register to receive your alert

Report an error